TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2010

Classical cyclophosphamide, methotrexate, and fluorouracil chemotherapy is more effective in triple-negative, node-negative breast cancer: results from two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.

Marco Colleoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.